Michel Vounatsos

BIIB

Michel Vounatsos serves as Chief Executive Officer at Biogen Inc. (BIIB). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$2.41M

Net Position

Net Seller

$2.41M

Companies Traded

BIIB

Active Period

Feb 2022

2 total trades

Most Recent

Sell BIIB

Feb 18, 2022 · $576.1K

Michel Vounatsos's Insider Trading at Biogen Inc. (BIIB)

Buys

0 · $0.00

Sells

2 · $2.41M

Total Shares Bought

Total Shares Sold

11,312

BIIB Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 18, 2022↗	Sell	2,746	$209.79	$576.1K	0
Feb 12, 2022↗	Sell	8,566	$214.59	$1.84M	0

Related Insiders

Nicole Murphy

Head of Pharm Ops and Tech

BIIBBuy · Feb 12, 2026

Nicole Murphy

officer: Head of Pharm Ops and Tech

BIIBBuy · Feb 12, 2026

Priya Singhal

officer: Head of Development

BIIBSell · Feb 9, 2026

Priya Singhal

Head of Development

BIIBSell · Feb 9, 2026

Rachid Izzar

Head of Global Product Strat.

BIIBSell · Feb 6, 2026

Adam Keeney

Head of Corporate Development

BIIBSell · Feb 6, 2026

Robin Kramer

Chief Financial Officer

BIIBSell · Feb 6, 2026

Christopher Viehbacher

President and CEO

BIIBSell · Feb 6, 2026

Explore More Insider Trading Data

BIIB Insider Trading Activity

View all insider trades at Biogen Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity